There is still time to join the 5K next week!
@ndevitomd
Assistant Prof, GI Oncologist @ Duke: immunotherapy, metastasis, and the immune microenvironment. TheDeVitoLab.org #FirstGen. USouthFlorida alum. Tufts residency survivor. Patients don’t fail treatments, treatments fail patients. Opinions=mine
There is still time to join the 5K next week!
Its March and that means colorectal cancer awareness month #crc
He makes a great case against her nomination thanks for sharing, I will share!
Including my former colleague Rich Carmona.
thehill.com/opinion/heal...
We won’t stand for it.
My incredible patient, a young mother who has overcome a stage IV, MSS CRC diagnosis is featured on Duke's Faces of Research.
She has only been treated on clinical trials, exhibiting a complete response to immunotherapy in the second line setting.
today.duke.edu/2026/02/face...
Another life lost too young to colorectal cancer, RIP James Van Der Beek. The time for better prevention, screening, and treatment is now. #CureCRC
“I am shocked and appalled,” one NCI scientist said. “We are moving funds away from so much promising research in order to do a preclinical study based on nonscientific ideas. It’s absurd.”
The CRUSH CRC 5K is just over a month away!
join our team here:
www.supportdukehealth.org/site/TR/Colo...
🚨 #REVIEW #PROGRESS 🚨
Fucosylation—the attachment of the dietary sugar L‑fucose to glycoproteins & glycolipids—is frequently altered in cancer. Bitaraf et al. outline its role in tumour progression and therapeutic response.
📖 👇
Thanks to @medpagetoday.com for interviewing me about our recent @jco-asco.bsky.social commentary on how medications can influence immunotherapy!
www.medpagetoday.com/hematologyon...
I appreciate the write up from @dukemedschool.bsky.social on our recent @jco-asco.bsky.social commentary regarding how common medications can interact with immunotherapy!
corporate.dukehealth.org/news/over-co...
“Of all the forms of inequality, injustice in health is the most shocking and inhumane because it often results in physical death" - Dr. MLK Jr.
My mom ran the HIV prevention program for Hillsborough county (before it was shut down by Jeb Bush) which was one of my first volunteering experiences, inspiring me to pursue medicine. I witnessed so much pain, and many people are still suffering - the depth of this cruelty cannot be overstated.
New @naturemedicine.bsky.social
The power of our mind to shape immune response, as seen in a randomized trial of trained neurofeedback for increased reward activity. More positive expectation-> more antibody response nature.com/articles/s41...
nature.com/articles/s41...
Anti-PD-1 > Anti-PD-L1, due to the existence of PD-L2. It may explain why PD-L1 is such a meh biomarker in many tumors, too.
ascopubs.org/doi/pdf/10.1...
Here is our publication in @jco-asco.bsky.social! We describe how common medications impact immunotherapy, how this affects practice and patients today, and outline ways to leverage this knowledge toward improved patient as well as our understanding of tumor immunology.
ascopubs.org/doi/10.1200/...
For the first time, the five-year survival rate for all cancers has reached 70 percent, according to a new report, a trend that reflects the effectiveness of early prevention and detection strategies, and advancements in treatment and care, experts say. https://wapo.st/45T6Zm3
***improved patient outcomes (need an edit feature!)
In summary: If we don't look, we don't know! we cover the immunotherapy compromising effects of corticosteroids and acetaminophen, and potentially beneficial effects of SSRIs, statins, GLP1 agonists, anti-histamines, and PCSK9 inhibitors. We can study this in many settings to modify management!
Here is our publication in @jco-asco.bsky.social! We describe how common medications impact immunotherapy, how this affects practice and patients today, and outline ways to leverage this knowledge toward improved patient as well as our understanding of tumor immunology.
ascopubs.org/doi/10.1200/...
I don't think you non-science people realize what it takes to get a grant funded by NIH. Started experiments in Sept 2021 to generate 3 new mouse mutants to model human disease. Prelim dara shows they have relevant disease phenotypes worthy of study. Need a small grant first to characterize /1
Figure showing the types of therapeutic cancer vaccines, The vaccines have been classified into four categories by how the antigens are selected and where the antigens are co-localised with antigen-presenting cells. Copyright: 2025 Elsevier Ltd. All rights are reserved.
🗨️ “Vaccines have done more to improve public health than any other medical intervention.”
A Viewpoint focuses on cancer vaccines and the future of immunotherapy: spkl.io/63322AYP7k
For every trainee who succeeds at getting some super difficult experiment to yield interesting results, there are another dozen who fruitlessly spun their wheels for years. My advice: explore many technically feasible experiments and follow up on interesting leads
High fat diets “ready the soil” for cancer to grow in the liver. This has been inferred to many degrees for years but its good to see some mechanism:
www.cell.com/cell/fulltex...
Americans & Europeans needlessly exposing African babies to preventable diseases just to see if they can find something that would justify their preexisting antivaccine beliefs is not only unscientific and actually anti-science, it is very much reminiscent of colonialist, racist human rights abuses
At the colorectal cancer alliance summit, where the goal is very, very clear:
Important PSA:
Prasad, Makary and others who claim that COVID19 vaccines killed 10 children are not telling the truth.
According to @jeremyfaust.bsky.social, the committee that worked on this question reported that there were ZERO deaths that they were certain were caused by the vaccines.
Well worth reading.